Quest wins CDC contract to sequence COVID-19 gene variants

By staff writers

January 19, 2021 -- Quest Diagnostics has received a contract from the U.S. Centers for Disease Control and Prevention (CDC) to provide genomic sequencing for a project aimed at identifying new mutations and patterns of transmission of SARS-CoV-2.

Under the collaboration, Quest will use a random set of samples collected from Quest's labs across the U.S. to assist the CDC in conducting a large-scale longitudinal genomic survey of the SARS-CoV-2 virus. Sequencing will be performed at Quest's diagnostics laboratory in San Juan Capistrano, CA.

After the viral genomes of random de-identified samples of positive cases are sequenced, Quest will provide the CDC with completed whole viral sequences. This data will then be combined with the results of other data provided to the CDC by national, state, academic, and commercial labs, according to Quest.

The company did not disclose financial terms of the deal.

FDA authorizes Quest's combined COVID-19 and flu RT-PCR test
The U.S. Food and Drug Administration (FDA) said it has authorized Quest Diagnostics' RC COVID-19 +Flu reverse transcription polymerase chain reaction...
Quest revenues jump nearly 43% in Q3
Quest Diagnostics announced a jump in its third-quarter revenues on continued demand for COVID-19 testing and the rapid recovery of healthcare utilization....
Anthem, Quest ink partnership
Anthem and Quest Diagnostics have announced a collaboration to improve healthcare delivery for both providers and patients.
Quest wins approval to increase capacity for COVID-19
Quest Diagnostics has received emergency use authorization from the U.S. Food and Drug Administration to test a new laboratory technique that could bolster...
FDA grants first coronavirus clearance for sample pooling to Quest
The U.S. Food and Drug Administration has granted Quest Diagnostics the first emergency use authorization for a SARS-CoV-2 molecular diagnostic for testing...

Copyright © 2021

Last Updated ls 1/19/2021 4:28:42 PM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current